# Tapentadol in Chronic Malignant Tumour Related Pain

> **NCT01264887** · PHASE3 · TERMINATED · sponsor: **Grünenthal GmbH** · enrollment: 31 (actual)

## Conditions studied

- Cancer
- Chronic Pain
- Pain

## Interventions

- **DRUG:** Tapentadol Prolonged Release

## Key facts

- **NCT ID:** NCT01264887
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Administrative reasons
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01264887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01264887, "Tapentadol in Chronic Malignant Tumour Related Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01264887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*